Business
-
Catalent Pharma Solutions has announced that it will invest $20 million to enhance pMDI clinical and commercial supply capabilities, along with other enhancements, at its Inhalation Center of Excellence in Research Triangle Park (RTP), North… Read more . . .
-
Lars Borgström Consulting has joined the Medicon Valley Inhalation Consortium (MVIC), bringing the group of companies involved in inhalation product development in the Skåne-Copenhagen region to 14 members. Borgström, the first recipient of RDD’s Charles… Read more . . .
-
The Bluetooth Special Interest Group (SIG) has named Asthmapolis a finalist in the “Breakthrough Products” category for the Bluetooth Breakthrough Awards. The FDA granted 510(k) clearance to the Asthmapolis inhaler sensor system and mobile app… Read more . . .
-
The Biomedical Catalyst, a joint program of the UK’s Medical Research Council and the Technology Strategy Board, has awarded a grant of up to £1.3M in matched funding to Prosonix for support of a research… Read more . . .
-
Teva Respiratory says that the ProAir HFA metered dose inhaler with dose counter for the treatment of asthma is now available. The albuterol MDI with dose counter was approved by the FDA in March 2012.… Read more . . .
-
The Carlyle group has agreed to sell Mitsubishi Chemical Holdings Corporation all outstanding shares of pharmaceutical capsule manufacturer Qualicaps. Products manufactured by Qualicaps include both gelatin and hypromellose capsules for use with dry powder inhalers.… Read more . . .
-
Discovery Laboratories has announce the launch of its Afectair airway connector for the delivery of aerosolized medications to infants in neonatal or pediatric intensive care units. The disposable device enables delivery of aerosolized drugs to… Read more . . .
-
Acorda Therapeutics says that it has completed its acquisition of Neuronex, including Neuronex’s diazepam nasal spray formulation, for $6.8 million. The company also announced that it plans to submit a 505(b)(2) NDA in 2013 for… Read more . . .
-
Matrixx Initiatives has voluntarily recalled a single lot of Zicam Extreme Congestion Relief nasal gel spray due to contamination with Burkholderia cepacia in a single sample. Zicam is a homeopathic product available over the counter… Read more . . .
-
SkyePharma has announced that AstraZeneca will pay $8 million in January 2013 “to settle certain disputes” resulting from AZ’s termination of their licensing deal for the Pulmicort MDI. The deal was terminated after AZ discontinued… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland